FimmCyte ApS: Financial statements 2025
CVR: 43432583
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
FimmCyte ApS (CVR 43432583) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -3,405,028 and a net result of DKK -2,175,185 compared with DKK -5,454,290 the year before. Equity in the 2025 report amounted to DKK -11,141,581.
- Gross Profit
- DKK -3,405,028
- Profit/Loss
- DKK -2,175,185
- Equity
- DKK -11,141,581
- Total Assets
- DKK 3,714,396
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -3.4M | -2.2M | -11.1M | 0 |
| 2024 | - | -5.5M | -5.5M | -9M | - |
Official annual report
How creditworthy is FimmCyte ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
FimmCyte ApS has published its annual report for 2024. Gross profit came to DKK -5,548,427, and the net result was DKK -5,454,290.
About FimmCyte ApS
FimmCyte ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2022. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Mohaned Mohamed Ahmed Ali Shilaih and Valentina Vongrad. The company is owned by FimmCyte AG. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -3,405,028 and a net result of DKK -2,175,185 compared with DKK -5,454,290 the year before. Equity in the 2025 report amounted to DKK -11,141,581.